Answers · Valuation & Worth
How do you value a patent: cost, market, or income method?
Updated June 2026
The short answer
There are three recognized methods, but they do not get equal weight in practice: ipCG's valuations lead with the income method and use the market method as a cross-check, an approach our ipValue Model has applied across more than $2 billion in supported transactions. The income method discounts the future cash flows a patent can credibly be assigned; the market method prices it against comparable transactions; the cost method, what it would take to recreate the protection, sets a floor but is rarely the right tool for a patent on its own.
When the methods disagree, the disagreement is information. A patent worth far more under the income method than the market method has value that depends on execution, and any sophisticated counterparty will price that risk.
Which method typically carries the most weight, by situation
| Situation | Typical emphasis |
|---|---|
| Internal planning, renew-or-lapse decisions | Income method for a directional read; cost method as a floor |
| Licensing negotiation | Income method (relief from royalty) cross-checked against market comparables |
| Fundraising and investor materials | Income method with fully documented assumptions, plus any market evidence |
| M&A and purchase price allocation | Income and market methods; cost is rarely persuasive to a buyer |
| Asset-based lending | Market-leaning: what the collateral could fetch in a transfer to a third party |
| Litigation damages | Set by legal standards through counsel and testifying experts, a separate discipline |
What each method measures and where it breaks
The cost method totals what reproducing the asset would cost: R&D, prosecution, the calendar time a competitor would burn. It sets a useful floor and it is the easiest to document, but it ignores demand entirely. An expensive patent on technology nobody wants fails the only test that matters.
The market method looks for comparable transactions, the way a real estate appraiser uses neighborhood sales. Its weakness is the data: most patent deals are confidential, the public ones skew unusual, and no two patents are truly comparable the way two condos are. Comparables inform a valuation; they rarely carry one alone.
The income method projects the cash flows attributable to the patent, then discounts them for time and risk. It is the most informative method and the most assumption-laden: how much of the product's margin does the patent actually protect, what royalty would a willing licensee pay, how long does the advantage last. Every one of those assumptions is a place a diligence team will push.
How the methods work together in practice
In our engagements the income method usually carries the most weight, typically through a relief-from-royalty analysis, which estimates what the owner would otherwise pay to license the same rights. That construction is popular for a reason: it is an income method that borrows its key input, the royalty rate, from market evidence, so two methods discipline each other inside one model.
Where useful comparable transactions exist, they discipline the royalty and the result; the cost method occasionally sets a floor, but it is seldom decisive for a patent and is not part of every valuation. A valuation that states its assumptions, shows the evidence behind the income number, and explains its cross-checks is one a board, an investor, or an acquirer can interrogate. A single black-box number is not.
Related questions
What is relief from royalty?
A widely used hybrid: estimate the royalty you would have to pay if someone else owned your patent, apply it to your revenue forecast, and discount the result. It is an income-method model fed by market-method inputs, which is why so many professional valuations rest on it.
Is the 25 percent rule still used?
Not credibly. The old rule of thumb assigned 25 percent of product profit to the patent, and US courts rejected it as damages evidence in 2011. It survives informally as a sanity check, but no valuation that has to withstand scrutiny should lead with it.
Which method do investors and acquirers trust most?
An income-method analysis with stated, checkable assumptions, supported by market evidence where it exists. What they distrust is any method presented alone with no visibility into the inputs.
What inputs do you need from us to run a valuation?
The patents and their prosecution history, the products or revenue streams they touch, your forecasts, and competitive context. We build the rest, including royalty support and comparable-transaction research.
Get a number built to be questioned
Tell us what decision the valuation has to support and who has to believe it. The discovery call is free and the proposal that follows is fixed-price.
Talk with Our TeamRelated
ipCapital Group is a consultancy, not a law firm, and nothing on this page is legal advice. Dollar figures on this page are typical market ranges for professional IP services, drawn from published sources and industry experience across a variety of providers. They are not an ipCG quote or rate card; every ipCG engagement is individually scoped and priced. See how our pricing works.